IVEY ENTREPRENEURSHIP CROSS-ENTERPRISE LEADERSHIP CENTRE Medical Technology Innovation Public Policy Drivers for Innovation & Adoption of Medical Technologies
Jeffrey S. Graham
Borden Ladner Gervais LLP
The current Canadian public policy environment
Ontario Venture Capital Fund
Health Technology Exchange
Ontario Emerging Technologies Fund
Ontario Innovation Demonstration Fund
SR & ED - Federal 20% non-refundable tax credit for public companies and a 35% refundable tax credit for private companies.
Granting programs and agencies:
Genome Canada, CIHR, NRC, NSERC, IRAP
Provincial Plan Listing Decisions
Quebec “15 year rule”
Implementing an effective right of appeal for innovators within Canada
Enhancing innovator Data Protection to U.S. and EU levels
Implementing a Patent Term Restoration system similar to that of our G7 competitors
Improving Health Canada regulatory review performance;
Targeting higher public reimbursement rates for innovative medicines and vaccines.
Expanding the definition of eligible research to better capture all aspects of clinical research, including all investments in clinical trials, as well as complementary investments in other forms of research partnerships not currently eligible for SR&ED credits;
Create flow through shares program for medical technologies;
Consideration of a refundable wage credit for R&D workers to better target and sustain employment in innovation.